{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:22:45Z","timestamp":1761862965192},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jpba.2010.08.015","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T06:41:00Z","timestamp":1282286460000},"page":"248-251","source":"Crossref","is-referenced-by-count":14,"title":["Development of liquid chromatographic enantiomer separation methods and validation for the estimation of (R)-enantiomer in eslicarbazepine acetate"],"prefix":"10.1016","volume":"54","author":[{"given":"Mahesh Kumar","family":"Mone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.B.","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2010.08.015_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nurt.2006.10.005","article-title":"Eslicarbazepine Acetate (BIA 2-093)","volume":"4","author":"Almeida","year":"2007","journal-title":"Neurotherapeutics: J. Am. Soc. Exp. NeuroTherapeutics"},{"key":"10.1016\/j.jpba.2010.08.015_bib0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0197-0186(01)00101-2","article-title":"The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine","volume":"40","author":"Parada","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jpba.2010.08.015_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.jpba.2010.08.015_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.07.010","article-title":"Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)","volume":"61","author":"Bialer","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jpba.2010.08.015_bib0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0920-1211(01)00231-5","article-title":"Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(\u2212)-10,11-dihydro-10-hydroxy carbamazepine","volume":"44","author":"Hainzl","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jpba.2010.08.015_bib0030","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/0091270005279364","article-title":"Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects","volume":"45","author":"Almeida","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2010.08.015_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.aca.2007.05.056","article-title":"Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection","volume":"596","author":"Alves","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2010.08.015_bib0040","article-title":"ICH draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology","volume":"vol. 60","author":"IFPMA","year":"1995"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708510004759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708510004759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T13:20:58Z","timestamp":1544275258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708510004759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0731708510004759"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2010.08.015","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}